口服抗凝治疗患者的桥接治疗：重点关注如何进行桥接治疗。 - Suppr

Suppr

超能文献

Bridging therapy in oral anticoagulated patients: focusing on how to do it.

作者信息

Palareti G

机构信息

Department of Angiology & Blood Coagulation "Marino Golinelli", University Hospital S. Orsola-Malpighi, Bologna, Italy.

出版信息

Intern Emerg Med. 2007 Dec;2(4):247-9. doi: 10.1007/s11739-007-0074-2.

DOI:10.1007/s11739-007-0074-2

PMID:18172591

Abstract

摘要

相似文献

Bridging therapy in oral anticoagulated patients: focusing on how to do it.口服抗凝治疗患者的桥接治疗：重点关注如何进行桥接治疗。

Intern Emerg Med. 2007 Dec;2(4):247-9. doi: 10.1007/s11739-007-0074-2.

[Bleeding during anti-vitamin K treatment. Incidence, risk factors and comparison with the new oral anticoagulants].[抗维生素K治疗期间的出血。发病率、危险因素及与新型口服抗凝剂的比较]

Medicina (B Aires). 2012;72(5):419-24.

[Atrial fibrillation: new anticoagulants are more effective and safer, but expensive].

Praxis (Bern 1994). 2014 Jun 18;103(13):785-6. doi: 10.1024/1661-8157/a001681.

[Oral anticoagulants. Large study finds minor risk of hemorrhage in the elderly].

MMW Fortschr Med. 2011 Sep 15;153(37):16.

Use of Direct Oral Anticoagulants in Special Populations.特殊人群中直接口服抗凝剂的应用

Hematol Oncol Clin North Am. 2016 Oct;30(5):1053-71. doi: 10.1016/j.hoc.2016.05.003. Epub 2016 Aug 9.

Factor Xa and thrombin as targets for new oral anticoagulants.Xa 因子和凝血酶作为新型口服抗凝剂的作用靶点。

Thromb Res. 2011 Jan;127 Suppl 2:S5-S12. doi: 10.1016/S0049-3848(10)70147-X.

Are New Oral Anticoagulants Safer Than Vitamin K Antagonists in the Treatment of Venous Thromboembolism?新型口服抗凝剂在治疗静脉血栓栓塞症方面是否比维生素K拮抗剂更安全？

Ann Emerg Med. 2016 Apr;67(4):455-7. doi: 10.1016/j.annemergmed.2015.08.018. Epub 2015 Oct 3.

Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.非维生素K拮抗剂口服抗凝药在静脉血栓栓塞管理中的获益-风险概况

Thromb Haemost. 2015 Feb;113(2):231-46. doi: 10.1160/TH14-06-0484. Epub 2014 Oct 16.

Novel oral anticoagulants: the potential relegation of vitamin K antagonists in clinical practice.新型口服抗凝剂：维生素K拮抗剂在临床实践中的潜在地位下降

Int J Clin Pract. 2010 Jun;64(7):835-8. doi: 10.1111/j.1742-1241.2010.02351.x.

Use of the Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism.直接口服抗凝剂在静脉血栓栓塞症治疗中的应用。

Hematol Oncol Clin North Am. 2016 Oct;30(5):1035-51. doi: 10.1016/j.hoc.2016.05.008. Epub 2016 Jul 20.

本文引用的文献

To bridge or not to bridge, that is the question.搭桥还是不搭桥，这是个问题。

Intern Emerg Med. 2007 Jun;2(2):145-7. doi: 10.1007/s11739-007-0043-9. Epub 2007 Jul 18.

The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians.手术时需要临时停用维生素K拮抗剂的患者管理：临床医生实用指南

Intern Emerg Med. 2006;1(2):96-104. doi: 10.1007/BF02936533.

Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.长期口服抗凝剂患者使用普通肝素或低分子肝素作为桥接治疗的临床结局：REGIMEN注册研究

J Thromb Haemost. 2006 Jun;4(6):1246-52. doi: 10.1111/j.1538-7836.2006.01908.x.

The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative.输血对非ST段抬高型急性冠脉综合征患者的影响：CRUSADE国家质量改进计划的结果

J Am Coll Cardiol. 2005 Oct 18;46(8):1490-5. doi: 10.1016/j.jacc.2005.06.072. Epub 2005 Sep 29.

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.维生素K拮抗剂的药理学与管理：第七届抗栓与溶栓治疗ACCP会议

Chest. 2004 Sep;126(3 Suppl):204S-233S. doi: 10.1378/chest.126.3_suppl.204S.

Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery.接受择期非心脏手术的机械心脏瓣膜患者围手术期抗凝治疗的医生偏好

Chest. 1999 Nov;116(5):1240-6. doi: 10.1378/chest.116.5.1240.

Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).心脏瓣膜病患者管理指南：执行摘要。美国心脏病学会/美国心脏协会实践指南工作组（心脏瓣膜病患者管理委员会）报告。

Circulation. 1998 Nov 3;98(18):1949-84. doi: 10.1161/01.cir.98.18.1949.

Management of anticoagulation before and after elective surgery.择期手术前后的抗凝管理。

N Engl J Med. 1997 May 22;336(21):1506-11. doi: 10.1056/NEJM199705223362107.

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.口服抗凝治疗的出血并发症：一项起始队列前瞻性协作研究（ISCOAT）。意大利口服抗凝治疗并发症研究。

Lancet. 1996 Aug 17;348(9025):423-8. doi: 10.1016/s0140-6736(96)01109-9.

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group.低分子量肝素与标准肝素预防腹部大手术后静脉血栓栓塞。血栓预防协作组。

Lancet. 1993 Jan 30;341(8840):259-65. doi: 10.1016/0140-6736(93)92614-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验